Protara
Booth number: 21
https://protaratx.com/
Description
Protara Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for cancer and rare diseases. Protara is developing intravenous choline chloride, a phospholipid substrate replacement therapy, for patients on parenteral support who are choline-deficient. Their investigational therapy, TARA-002, is a cell-based therapy in development for non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs).